Currently, there are 213.56M common shares owned by the public and among those 149.26M shares have been available to trade.
The company’s stock has a 5-day price change of 0.77% and 57.57% over the past three months. CAN shares are trading -43.29% year to date (YTD), with the 12-month market performance down to -29.95% lower. It has a 12-month low price of $0.72 and touched a high of $3.50 over the same period. CAN has an average intraday trading volume of 5.38 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 22.47%, 28.20%, and 12.72% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Canaan Inc ADR (NASDAQ: CAN) shares accounts for 19.81% of the company’s 213.56M shares outstanding.
It has a market capitalization of $349.72M and a beta (3y monthly) value of 3.06. The earnings-per-share (ttm) stands at -$1.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 13.64% over the week and 7.88% over the month.
Earnings per share for the fiscal year are expected to increase by 75.46%, and 80.00% over the next financial year.
Looking at the support for the CAN, a number of firms have released research notes about the stock. B. Riley Securities stated their Buy rating for the stock in a research note on September 18, 2024, with the firm’s price target at $2. Rosenblatt coverage for the Canaan Inc ADR (CAN) stock in a research note released on September 11, 2024 offered a Buy rating with a price target of $3. H.C. Wainwright was of a view on July 06, 2022 that the stock is Buy, while The Benchmark Company gave the stock Buy rating on June 08, 2022, issuing a price target of $9. DA Davidson on their part issued Buy rating on April 05, 2022.
